Uptick Network – Interview with CFO Andrew Kucharchuk with OncBioMune Pharmaceuticals, Inc.
Feb 16, 2016, 06:06 PM
Everett Jolly interviews Andrew Kucharchuk, CFO for OncBioMune Pharmaceuticals, Inc. (OBMP) and discussing Phase 2 Trials for their new drug that is designed for stage 4 prostate cancer patients.